No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: Overview of a case-control study of breast cancer risk in Japan

International Journal of Clinical Oncology

Volumn 13, Issue 1, 2008, Pages 8-11

  Saeki, Toshiaki ^a   Sano, Muneo ^b   Komoike, Yoshifumi ^c   Sonoo, Hiroshi ^d   Honjyo, Hideo ^e   Ochiai, Kazunori ^f   Kobayashi, Tadashi ^f   Aogi, Kenjiro ^g   Sato, Nobuaki ^b   Sawai, Seiji ^e   Miyoshi, Yoshio ^h   Takeuchi, Masahiro ⁱ   Takashima, Shigemitsu ^g  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Niigata Cancer Center   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^h OSAKA UNIVERSITY   (Japan)

ⁱ KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CORRELATION ANALYSIS; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SMOKING;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; JAPAN; RISK FACTORS;

EID: 40149106109     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0728-0     Document Type: Review

References (21)

1. The Editorial Board of Cancer Statistics in Japan (2003) Cancer statistics in Japan-2003. Foundation for Promotion of Cancer Research, Tokyo
2. Saeki T (2007) A report of results of a case-control study for relationship between hormone replacement therapy and breast cancer risk in Japan (in Japanese).
3. Henderson BE, Bernstein L (1991) The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 18(Suppl 1):S11-S17
4. Ravdin PM, Cronin KA, Howlader N, et al. (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674
5. Willett WC, Rockhill B, Hankinson SE, et al. (2000) Epidemiology and nongenetic causes of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast. Lippincott, Williams and Wilkins, Philadelphia, p 175
6. Hoegh H, McKendry CJ, Wright WE, et al. (unpublished report, 1992) Cancer incidence by race/ethnicity California, 1988-1989. Available from the California Department of Health Services, Sacramento, CA
7. Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617-631
8. Kelsey JL, Fischer DB, Holford TR, et al. (1981) Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 67:327-333
9. Key TJ, Appleby PN, Reeves GK, et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226
10. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321-333
11. Cho E, Spiegelman D, Hunter DJ, et al. (2003) Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 95:1079-1085
12. Harashima E, Nakagawa Y, Urata G, et al. (2007) Time-lag estimate between dietary intake and breast cancer mortality in Japan. Asia Pac J Clin Nutr 16:193-198
13. Collaborative Group on Hormonal factors in Breast Cancer. (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358: 1389-1399
14. Eisinger F, Bruke W (2002) Breast cancer and breastfeeding. Lancet 361:176-177
15. Smith-Warner SA, Spiegelman D, Yaun SS, et al. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279:535-540
16. Thune I, Brenn T, Lund E, et al. (1997) Physical activity and the risk of breast cancer. N Engl J Med 336:1269-1275
17. Marshall LM, Hunter DJ, Connolly JL, et al. (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297-301
18. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151
19. Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
20. The National Health and Nutrition Survey in Japan, 2004 (2004) Ministry of Health, Labor and Welfare Japan, Tokyo
21. Nagata C, Mizoue T, Tanaka K, et al.; Research Group For Development And Evaluation of Cancer Prevention Strategies in Japan (2006) Jpn J Clin Oncol 36:387-394